TNXP · Tonix Pharmaceuticals Holding Corp.
$13.66
+1.21 (+9.72%)
At close · Aug 25
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$213.53M
Shares
17.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $3,168,830 |
| Jessica Morris | Chief Operations Officer | $1,226,269 |
| Gregory Sullivan | Chief Medical Officer | $1,216,542 |
| Bradley Saenger | Chief Financial Officer | $1,143,513 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $1,809,767 |
| Gregory Sullivan | Chief Medical Officer | $922,444 |
| Jessica Morris | Chief Operations Officer | $887,741 |
| Bradley Saenger | Chief Financial Officer | $849,981 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $2,050,065 |
| Gregory Sullivan | Chief Medical Officer | $951,998 |
| Jessica Morris | Chief Operations Officer | $928,599 |
| Bradley Saenger | Chief Financial Officer | $904,913 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $4,580,167 |
| Gregory Sullivan | Chief Medical Officer | $1,478,661 |
| Jessica Morris | Chief Operations Officer | $1,391,212 |
| Bradley Saenger | Chief Financial Officer | $1,236,430 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $7,708,389 |
| Gregory Sullivan | Chief Medical Officer | $2,247,785 |
| Jessica Morris | Chief Operations Officer | $1,769,885 |
| Bradley Saenger | Chief Financial Officer | $1,769,885 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $3,874,822 |
| Gregory Sullivan | Chief Medical Officer | $1,382,420 |
| Bradley Saenger | Chief Financial Officer | $1,091,808 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $1,288,273 |
| Gregory Sullivan | Chief Medical Officer | $652,393 |
| Bradley Saenger | Chief Financial Officer | $578,112 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Seth Lederman | Chief Executive Officer | $1,477,445 |
| Gregory Sullivan | Chief Medical Officer | $721,855 |
| Bradley Saenger | Chief Financial Officer | $616,235 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Seth Lederman | Interim Chief Medical Officer | Appointed | 2026-08-18 |
| Gregory M. Sullivan | Chief Medical Officer | Retired | 2026-07-21 |
| James Treco | Director | Appointed | 2026-05-07 |
| Carolyn Taylor | Director | Appointed | 2026-05-07 |
| R. Newcomb Stillwell | Director | Appointed | 2026-05-07 |
| Adeoye Olukotun | Director | Appointed | 2026-05-07 |
| James Hunter | Director | Appointed | 2026-05-07 |
| David Grange | Director | Appointed | 2026-05-07 |
| Margaret Smith Bell | Director | Appointed | 2026-05-07 |
| Richard Bagger | Director | Appointed | 2026-05-07 |
| Seth Lederman | Director | Appointed | 2026-05-07 |
| James Hunter | member of the Board | Appointed | 2025-06-13 |
| Siobhan Fogarty | Chief Technology Officer | Appointed | 2025-02-04 |
| Newcomb Stillwell | director | Appointed | 2023-02-23 |
| Carolyn E. Taylor | director | Appointed | 2021-07-19 |
| Bradley Saenger | Chief Financial Officer | Appointed | 2021-02-26 |
| Richard Bagger | director | Appointed | 2020-06-10 |
| John Rhodes | Board | Resigned | 2020-06-10 |
Key facts
CIK
1430306
CUSIP
890260839
13F (30d)
91 filings
90 filers
Visit website
Investor relations